Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · IEX Real-Time Price · USD
48.38
+0.36 (0.75%)
At close: Jul 19, 2024, 4:00 PM
48.35
-0.03 (-0.06%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Keros Therapeutics Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Keros Therapeutics stock have an average target of 88.67, with a low estimate of 60 and a high estimate of 105. The average target predicts an increase of 83.28% from the current stock price of 48.38.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for KROS stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 4 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Initiates $102 | Buy | Initiates | $102 | +110.83% | Jun 25, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $100 | Strong Buy | Maintains | $100 | +106.70% | Jun 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $100 | Strong Buy | Reiterates | $100 | +106.70% | Jun 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $100 | Strong Buy | Reiterates | $100 | +106.70% | May 9, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $105 | Buy | Maintains | $105 | +117.03% | Mar 27, 2024 |
Financial Forecast
Revenue This Year
6.47M
from 151.00K
Increased by 4,181.46%
Revenue Next Year
7.98M
from 6.47M
Increased by 23.48%
EPS This Year
-4.95
from -5.20
EPS Next Year
-5.26
from -4.95
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 31.6M | 65.6M | 138.6M | 376.8M | 870.3M |
| Avg | 6.5M | 8.0M | 51.8M | 145.7M | 422.9M |
| Low | n/a | n/a | n/a | n/a | 7.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 20,818.5% | 915.5% | 1,635.6% | 627.1% | 497.5% |
| Avg | 4,181.5% | 23.5% | 549.2% | 181.0% | 190.3% |
| Low | - | - | - | - | -94.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -4.49 | -4.37 | -2.17 | 2.06 | 7.14 |
| Avg | -4.95 | -5.26 | -4.80 | -3.06 | 0.43 |
| Low | -5.43 | -6.47 | -7.44 | -6.32 | -5.88 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.